Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.
The report details the trend, potential and market size of Bipolar Disorders and Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bipolar Disorders and Treatmentmarket, defines the market attractiveness level of Bipolar Disorders and Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bipolar Disorders and Treatment industry, describes the types of Bipolar Disorders and Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bipolar Disorders and Treatment market and the development prospects and opportunities of Bipolar Disorders and Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bipolar Disorders and Treatment market in Chapter 13.
By Player:
Janssen Pharmaceuticals
Otsuka Holdings
AstraZeneca
GlaxoSmithKline
Novartis
Eli Lilly
AbbVie
Pfizer
Allergan
By Type:
Mood Stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety
By End-User:
Hospital
Pharmacy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bipolar Disorders and Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bipolar Disorders and Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bipolar Disorders and Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bipolar Disorders and Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bipolar Disorders and Treatment Market Analysis and Outlook to 2022
-
7.1 Global Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.2 United States Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.3 Europe Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.4 China Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.5 Japan Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.6 India Bipolar Disorders and Treatment Consumption (2017-2022)
-
7.7 South Korea Bipolar Disorders and Treatment Consumption (2017-2022)
8 Region and Country-wise Bipolar Disorders and Treatment Market Analysis and Outlook to 2028
-
8.1 Global Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.2 United States Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.4 China Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.6 India Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Bipolar Disorders and Treatment Consumption Forecast (2022-2028)
9 Global Bipolar Disorders and Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Bipolar Disorders and Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mood Stabilizer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anticonvulsant Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antipsychotic Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antidepressant Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Antianxiety Consumption and Growth Rate (2017-2022)
-
9.2 Global Bipolar Disorders and Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Bipolar Disorders and Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Bipolar Disorders and Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mood Stabilizer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anticonvulsant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Antianxiety Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bipolar Disorders and Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Bipolar Disorders and Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bipolar Disorders and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bipolar Disorders and Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bipolar Disorders and Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bipolar Disorders and Treatment Market Competitive Analysis
-
14.1 Janssen Pharmaceuticals
-
14.1.1 Janssen Pharmaceuticals Company Details
-
14.1.2 Janssen Pharmaceuticals Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Product and Service
-
14.2 Otsuka Holdings
-
14.2.1 Otsuka Holdings Company Details
-
14.2.2 Otsuka Holdings Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Otsuka Holdings Bipolar Disorders and Treatment Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Bipolar Disorders and Treatment Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Bipolar Disorders and Treatment Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Bipolar Disorders and Treatment Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Bipolar Disorders and Treatment Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Bipolar Disorders and Treatment Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Bipolar Disorders and Treatment Product and Service
-
14.9 Allergan
-
14.9.1 Allergan Company Details
-
14.9.2 Allergan Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Allergan Bipolar Disorders and Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bipolar Disorders and Treatment
-
Figure Bipolar Disorders and Treatment Picture
-
Table Global Bipolar Disorders and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorders and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorders and Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bipolar Disorders and Treatment Consumption by Country (2017-2022)
-
Figure United States Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bipolar Disorders and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar Disorders and Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bipolar Disorders and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mood Stabilizer Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsant Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotic Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressant Consumption and Growth Rate (2017-2022)
-
Figure Global Antianxiety Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Mood Stabilizer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antianxiety Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bipolar Disorders and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bipolar Disorders and Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Bipolar Disorders and Treatment Product and Service
-
Table Otsuka Holdings (Foundation Year, Company Profile and etc.)
-
Table Otsuka Holdings Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Holdings Bipolar Disorders and Treatment Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bipolar Disorders and Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bipolar Disorders and Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Bipolar Disorders and Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bipolar Disorders and Treatment Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bipolar Disorders and Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bipolar Disorders and Treatment Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Bipolar Disorders and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Bipolar Disorders and Treatment Product and Service
-
